semaglutide backorder fda shortage resolved feb 21 2025 As of February 21, 2025, the updated its drug Demand Rising for 'Bootlegged' Weight-Loss

Therefore, a study like ours is not able to separate the effect of weight loss and medication on cardiovascular events. Jayne Morgan, MD, a cardiologist and the Executive Director of Health and Community Education at the Piedmont Healthcare Corporation in Atlanta, GA, who was not involved in the meta-analysis, also noted that [the meta-analysis] does seem to address this with the random effects model which can be a powerful tool statistically, allowing the capture of the variability in weights across the studies. Certain effects of semaglutide are already known to affect heart health directly, said Saad, who further pointed out that the drug stabilizes atherosclerotic plaques, preventing the development of an acute myocardial infarction, and improves systemic inflammation caused by obesity. Semaglutides, said Morgan, act directly on blood vessels by improving blood flow to the heart and lowering blood pressure, on the kidneys by reducing the rate of GFR [glomerular filtration rate] decline, on the liver by reducing steatosis and improving cholesterol profile, and also on the central nervous system. If semaglutide provides direct cardiovascular benefits, does the meta-analysis imply the drug may have value for people at risk of cardiovascular disease who do not have diabetes, overweight, or obesity

These incretin-based medications work by mimicking naturally occurring hormones that enhance insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways

For those without insurance, we explore all possible avenues to enable access to this vital treatment

But here's what matters: your body already produces GLP-1 naturally, and specific foods and nutrients can genuinely influence how much you make

Ideal for

Liraglutide is the second GLP-1RA to be approved after exenatide